Lyra Therapeutics, Inc. announced the appointment of Jim Tobin to its Board of Directors (BOD). The former President and Chief Executive Officer of both Boston Scientific Corporation and Biogen Inc., Mr. Tobin currently serves as Chairman of the Board at TransMedics, Inc. and Board Member of each of Globus Medical Inc.
Market Closed -
Other stock markets
|
5-day change | 1st Jan Change | ||
0.3284 USD | -0.79% | +0.71% | -93.73% |
EPS Revisions
1st Jan change | Capi. | |
---|---|---|
-93.73% | 20.18M | |
+52.36% | 56.69B | |
-3.86% | 41B | |
+38.14% | 38.11B | |
-12.01% | 26.89B | |
+14.13% | 25.59B | |
-21.62% | 18.59B | |
+0.21% | 12.39B | |
+25.96% | 11.99B | |
+23.02% | 11.88B |
- Stock Market
- Equities
- LYRA Stock
- News Lyra Therapeutics, Inc.
- Lyra Therapeutics, Inc. Appoints Jim Tobin to Board of Directors